Washington – A pediatric vaccine for respiratory syncytial virus (RSV),a highly contagious, common respiratory virus that infects the nose, throat, and lungs, is on hold, per US Food and Drug Administration`s instructions. An FDA document shows that a phase 1 trial of two experimental Moderna RSV vaccines in infants aged five to eight months was paused in July as five …